1
项与 CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy) 相关的临床试验Clinical Trial of CD19/CD22 Dual Target CAR-T Cells in the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Prospectively evaluate the safety and effectiveness of CD19/CD22 dual-target CAR-T cells in the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.
100 项与 CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy) 相关的临床结果
100 项与 CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy) 相关的转化医学
100 项与 CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy) 相关的专利(医药)
100 项与 CD19/CD22 dual-target CAR-T cells (Shenzhen Universtiy) 相关的药物交易